# Interventional Bioremediation of Microbiota in Metabolic Syndrome

> **NCT02730962** · PHASE2 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 12 (actual)

## Conditions studied

- Pre-Diabetes

## Interventions

- **DRUG:** Vancomycin
- **OTHER:** Placebo
- **DRUG:** Neomycin
- **DRUG:** Clindamycin
- **PROCEDURE:** Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT02730962
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Delays in IND approval caused a lack of funding to conduct the trial.
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730962, "Interventional Bioremediation of Microbiota in Metabolic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02730962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*